Literature DB >> 10398426

Cytogenetic clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy.

K van Lom1, A B Houtsmuller, W L van Putten, R M Slater, B Löwenberg.   

Abstract

In the myelodysplastic syndrome (MDS), cytogenetic abnormalities are often present and can be used as markers in studies for cell lineage involvement. Little is known of the involvement of the megakaryocytic lineage due to the variable ploidy of these cells. We applied dual-color fluorescence in situ hybridization (FISH) to routinely prepared bone marrow (BM) smears of cytogenetically normal patients and seven patients with MDS and monosomy 7 or trisomy 8. Probes specific for the centromeric regions of chromosomes 7 and 8 were detected with fluorescein isothiocyanate (FITC) and Texas Red, respectively. This enabled us to assess the ratio between the numbers of chromosomes 7 and 8 in the polyploid cells. We utilized confocal laser scanning microscopy to count the FITC and Texas Red FISH signals in the different focal layers of the megakaryocytes. Fifty-six megakaryocytes in six normal BM smears were analyzed, giving a mean ratio of 1.0, a standard deviation (SD) of 0.12, and a range of 0.8-1.33. This ratio was applied to evaluation of clonal involvement of individual megakaryocytes in the patients with MDS. In two patients with monosomy 7, the majority of the megakaryocytes were monosomic. In the five patients with trisomy 8, all or a majority of the analyzed megakaryocytes were trisomic. These results add direct evidence that in MDS megakaryocytes are involved in the malignant clone. Genes Chromosomes Cancer 25:332-338, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10398426     DOI: 10.1002/(sici)1098-2264(199908)25:4<332::aid-gcc4>3.3.co;2-w

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Internuclear chromosome distribution of dysplastic megakaryocytes in myelodysplastic syndromes is dependent on the level of ploidy.

Authors:  Claudia Münch; Annette M May; Dieter Hauschke; Jasmine Roth; Silke Lassmann; Martin Werner
Journal:  Chromosoma       Date:  2011-02-01       Impact factor: 4.316

2.  Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.

Authors:  Chun-Mei Fu; Zi-Xing Chen; Dan-Dan Liu; Jun Zhang; Jin-Lan Pan; Jian-Ying Liang
Journal:  Int J Hematol       Date:  2014-11-28       Impact factor: 2.490

3.  Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes.

Authors:  Julia Fröbel; Ron-Patrick Cadeddu; Sonja Hartwig; Ingmar Bruns; Christian M Wilk; Andrea Kündgen; Johannes C Fischer; Thomas Schroeder; Ulrich G Steidl; Ulrich Germing; Stefan Lehr; Rainer Haas; Akos Czibere
Journal:  Mol Cell Proteomics       Date:  2013-02-04       Impact factor: 5.911

4.  Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows.

Authors:  Xiao Li; Lingyun Wu; Shaoxu Ying; Chunkang Chang; Quan Pu
Journal:  Int J Hematol       Date:  2008-02-07       Impact factor: 2.490

5.  Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.

Authors:  Judith Strapatsas; Elena Calina Barbulescu; Michael Lauseker; Jennifer Kaivers; Barbara Hildebrandt; Kathrin Nachtkamp; Corinna Strupp; Martina Rudelius; Rainer Haas; Ulrich Germing
Journal:  Ann Hematol       Date:  2021-07-29       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.